Radyus Research Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Radyus Research's estimated annual revenue is currently $4.3M per year.(i)
  • Radyus Research's estimated revenue per employee is $155,000

Employee Data

  • Radyus Research has 28 Employees.(i)
  • Radyus Research grew their employee count by 4% last year.

Radyus Research's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M60%N/AN/A
#2
$1.7M11-8%N/AN/A
#3
$2.3M1550%N/AN/A
#4
$1.1M70%N/AN/A
#5
$17.1M1105%$0.07BN/A
#6
$4M26-7%N/AN/A
#7
$0.8M50%N/AN/A
#8
$1.1M717%N/AN/A
#9
$7.8M502%N/AN/A
#10
$1.7M1110%N/AN/A
Add Company

What Is Radyus Research?

We are a collaborative research organization, offering a wide range of preclinical drug development services combined with comprehensive scientific and strategic consulting. We go beyond the traditional contract research organization to closely collaborate with your team and help you achieve both drug and business development goals. We work with early-stage biotech and pharma companies: ▪️ Biotech startups ▪️ Virtual companies ▪️ Academic spinouts. We simplify the CRO experience. You can now work with just one CRO for the majority of your drug development needs: ▪️ Preclinical drug development services: bioanalytical, biomarkers, molecular biology, immunoassays, and animal models ▪️ Therapeutic areas: infectious diseases, immunology, oncology, metabolic diseases, and neurological diseases ▪️ Therapeutic platforms: small molecules, complex biologics, vaccines, and cell and gene therapies. Our services are designed to help you efficiently reach the next value inflection point and attract attention of pharma buyers and investors. Email us to start the conversation: ✉ support@radyusresearch.com

keywords:N/A

N/A

Total Funding

28

Number of Employees

$4.3M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2M28-30%$12.7M
#2
$2.8M28N/AN/A
#3
$6.3M2812%N/A
#4
$4.9M280%N/A
#5
$4.1M28N/AN/A